The role of negatively signaling NK cell receptors of the Ly49 family on the specificity of the acute CD8 
Many viruses induce a strong cytotoxic T-lymphocyte (CTL) response, occurring as a consequence of the selective expansion of preexisting CD8 ϩ cells whose T-cell receptors (TCR) can recognize virus-encoded peptides in association with major histocompatibility (MHC) class I molecules (30) . These differentiated T-cell clones are endowed with cytolytic and gamma interferon-producing capacities, enabling them to manifest antiviral activity against virus-infected target cells displaying those peptides. Our understanding of this response is complicated by its degeneracy, as many virus-specific CD8 ϩ T-cell clones cross-react with cells infected with other viruses or with uninfected cells displaying foreign MHC antigens. Indeed, high levels of allospecific CTL activity directed against discrete MHC class I alloantigens have been described in mice infected with lymphocytic choriomeningitis virus (LCMV), vaccinia virus, murine cytomegalovirus, herpes simplex virus, and Pichinde virus (7, 15, 31) and in humans with Epstein-Barr virus (2, 27, 28) .
A further complication to understanding the nature of the virus-induced CTL response relates to the recent observation that, like all NK cells, some T cells express negatively regulating signaling molecules. Ly49 is a multigenic family which encodes homodimeric C-type lectin-like receptors expressed primarily on murine NK cells (reviewed in reference 23). Inhibitory Ly49 receptors have been identified on a small, predominantly CD8 ϩ subset of murine T cells, many of which coexpress the NK cell marker, NK1.1 (10, 17) . Interactions of most Ly49 receptors with their ligands, the ␣1/␣2 peptidebinding domains of specific MHC class I alleles, result in the delivery of inhibitory signals to the cell (26) . As such, targets expressing H2D d and/or H2L d inhibit cytotoxicity mediated by NK cells expressing the receptor Ly49G2, for which these class I molecules are ligands. This inhibition is negated by the addition of monoclonal antibodies (MAbs) that recognize Ly49G2 protein (4D11), H-2D d , or H-2L d (12) . Similarly, interaction of the Ly49G2 receptor on interleukin-2 (IL-2)-activated CD3 ϩ NK1.1 ϩ T cells with H2D d inhibited lysis and cytokine production, and this effect was negated by antibodies to Ly49G2 or H2D d (10, 17) . The above studies were performed either with NK cells or with IL-2-activated T cells that manifest NK-like activity, but the role of these negative regulatory molecules on the repertoire and function of T cells during viral infection is not understood. LCMV infection of mice represents a useful model system for studying the activation and function of CD8 ϩ T cells (15) , and in this study we report on a distinct subset of CD8 ϩ
Ly49G2
ϩ T cells which kill LCMV-infected syngeneic targets, but are impaired in their ability to lyse allogeneic P815 (H2 d ) targets.
MATERIALS AND METHODS
Infection of mice. C57BL/6 (H2 b ) male mice (Jackson Laboratory, Bar Harbor, Maine) 6 to 8 weeks of age were infected intraperitoneally with 4 ϫ 10 4 PFU of the Armstrong strain of LCMV as described previously (29) .
Cytotoxicity assay. Cell-mediated cytotoxicity was determined by using a 51 Cr release assay as described previously (15) . Selected wells contained 5 g of anti-Ly49G2 MAb (4D11 [12] ). Lytic units were calculated by the exponential fit method (20) . One lytic unit was defined as the number of cells required to lyse 15% of a population of 5 ϫ 10 3 target cells in a 6-h assay. Lytic unit values are expressed as mean Ϯ standard error of the mean. The spontaneous release for each target used in these assays was Ͻ20%. Target cells. MC57G (H2 b ), a methylcholanthrene-induced fibroblast cell line from C57BL/6 mice, and P815 (H2 d ), a DBA/2-derived mastocytoma, were propagated as described previously (15 6 freshly isolated spleen cells were pretreated with 1 l of unlabeled MAb 2.4G2 and 10 l of normal mouse serum for 10 min before being triple stained with combinations of MAb conjugates anti-CD8-allophycocyanin (APC), anti-Ly49G2-FITC, anti-Ly49A-FITC, anti-NK1.1-PE, anti-CD44-PE (Pharmingen), in a 100-l volume. Cells were then fixed with 1% paraformaldehyde (J. T. Baker, Inc., Phillipsburg, N.J.), and analyzed using CELLQuest software (FacsCalibur; Becton Dickinson).
CDR3 length spectratyping. Total RNA from sorted CD8 ϩ Ly49G2 ϩ and CD8 ϩ Ly49G2 Ϫ populations was purified using Trizol total RNA isolation reagent (GibcoBRL, Grand Island, N.Y.) as instructed by the manufacturer. Purified RNA was converted to cDNA by reverse transcription-PCR (RT-PCR) using V␤8.1 and C␤ primers, and CDR3 length spectratyping was performed as described previously (9, 18) .
RESULTS

A subset of CD8
؉ T cells coexpressing Ly49G2 is expanded following LCMV infection. The anti-Ly49G2 MAb (4D11) identifies a substantial subset of NK cells in the spleens from naive C57BL/6J mice (Jackson Laboratory), and a smaller but significant subpopulation of CD8 ϩ T cells (Fig. 1 ). Minor subpopulations of CD8 ϩ cells bearing Ly49A and Ly49C/I, but not Ly49D, were also detected (data not shown), as described previously (17) . Interestingly, the overwhelming majority of these naive CD8
ϩ Ly49G2 ϩ cells coexpressed the activation marker CD44, consistent with a memory phenotype and having been activated in vivo. The intensity of CD8 staining on Ϫ , 9%). For a more detailed examination of TCR usage, we performed CDR3 length spectratyping on sorted CD8
ϩ Ly49G2 ϩ cells from the spleens of day 8 LCMV-infected mice. An RT-PCR with specific V␤ and C␤ primers competitively amplifies TCR with specific V␤ sequences but different CDR3 regions (18) . The V␤8.1 TCR was chosen because LCMV-specific lysis is highly represented within this population (15) . Whereas the V␤8.1 spectratype of T cells from naive mice has a characteristic Gaussian distribution, T cells from LCMV-infected mice have a skewed appearance, indicative of expanding clones of T cells (9) . Extension of PCR-amplified DNA using J␤2.2 and J␤2.7 primers showed that the CDR3 lengths used by CD8 ϩ clones in the Ly49G2 ϩ fraction differed from those in the Ly49G2 Ϫ subset, suggesting a distinct subset within the larger CD8 ϩ population (Fig.  2) . This conclusion was supported by our observation that Ly49G2-depleted CD8 ϩ cells adoptively transferred into ␣␤ TCR knockout mice failed to upregulate expression of this marker in response to LCMV infection (data not shown).
The cytotoxic activity of LCMV-induced CD8 ؉ Ly49G2 ؉ cells ex vivo. Freshly sorted CD8 ϩ Ly49G2 Ϫ spleen cells, when tested directly in a 51 Cr release cytotoxicity assay, lysed both LCMV-infected syngeneic MC57G and uninfected allogeneic P815 targets, as described previously (15) . The CD8
ϩ Ly49G2
ϩ population, however, demonstrated poor killing against P815 targets but lysed LCMV-infected syngeneic MC57G cells (Fig.  3A) . Neither Ly49G2 ϩ nor Ly49G2 Ϫ CD8 ϩ cells mediated any substantial killing against the prototypic NK cell target, YAC-1 (Fig. 3B) , which we routinely use as a very sensitive target in NK cell assays (31) . Ly49G2 receptor from that observed immediately postsort (Fig. 4) . Hence, Ly49G2 appears to be stably expressed on a CD8 ϩ T-cell subset and is not turned on and off on subpopulations of CD8 ϩ cells. A significant percentage of CD8 ϩ cells expressing Ly49G2 were positive for another Ly49 family member, Ly49A, which also inhibits NK cell activity upon interaction with H2D d (4), but none were positive for Ly49C, which can recognize autologous MHC (1). By comparison, both Ly49A and Ly49C are coexpressed on subsets of NK1.1 ϩ
Analysis of cultured LCMV-induced CD8
Ly49G2
ϩ cells in naive C57BL/6 mice (24). Expression of Ly49G2 by CD8 ϩ T cells was not restricted to the NK1.1 ϩ T-cell subset (10, 17), but it is notable that a significant proportion of the CD8 ϩ Ly49G2 ϩ and not the CD8 ϩ Ly49G2 Ϫ population displayed this NK cell marker (Fig. 4) . This distinctive phenotype of cultured CD8 ϩ Ly49G2 ϩ cells from day 8 LCMV-infected C57BL/6J mice was associated with a characteristic cytotoxic profile, reflecting that of the freshly isolated cells. Whereas both CD8 ϩ Ly49G2 ϩ and CD8 ϩ Ly49G2 Ϫ cells lysed syngeneic MC57G cells infected with LCMV, only the Ly49G2 Ϫ cells lysed allogeneic, H2 dϩ P815 cells, typical of LCMV-induced CTL (Fig. 5A) (15) . CD8 
ϩ cells exhibited negligible lysis against uninfected syngeneic (H2 b ) MC57G (Fig. 5A ) or L5neo3 (data not shown) targets, in contrast to the considerable lysis mediated against the latter target by IL-2-treated, CD3
ϩ Ly49G2 ϩ cells examined in a previous study (17) . As with freshly isolated CD8 ϩ
ϩ cells (Fig. 3B) , lysis mediated by cultured CD8 ϩ Ly49G2 ϩ cells against YAC-1 targets was less than 3% at an effector/target ratio of 10:1, again in contrast to IL-2-activated CD3 ϩ Ly49G2 ϩ cells (17) . Hence, the activity of our CD8 ϩ Ly49G2 ϩ fraction appears to be more typical of T cells than of NK cells.
The absence of allospecific CTL activity against H2 d in the CD8 ϩ Ly49G2 ϩ fraction could have been due to a lack of Ly49G2 ϩ precursor cells with TCR that can recognize H2 d or to the inhibited expansion of a potentially alloreactive CTL population due to the presence of Ly49G2 on the CD8 ϩ cell surface. Alternatively, the cytotoxic activity of LCMV-induced allospecific CTL may have been inhibited by the interaction of Ly49G2 with its H2 d ligand on the target cell. Killing against P815 could not be restored with a blocking MAb against Ly49G2 MAb (Fig. 5B) , a result which favors the hypothesis that allospecific CTL are excluded from the Ly49G2 ϩ fraction.
Specificity of the LCMV-specific response mediated by cultured CD8
؉ Ly49G2 ؉ cells. The bulk of the CTL response to LCMV in H2 b mice is directed against three structural epitopes, GP33, GP276, and NP396, which are presented by MHC class I H2D b molecules (6, 25) . Studies were done to examine the viral peptide specificity of the two CD8 ϩ cell populations. L5neo3 cells were pulsed overnight with GP33, GP276, or NP396. The CD8 ϩ Ly49G2 ϩ and Ly49G2 Ϫ subsets both demonstrated effective killing against L5neo3 (H2D b ) targets pulsed with 1 M GP33 or NP396. However, killing against GP276-pulsed targets by CD8 ϩ Ly49G2 ϩ cells was substantially reduced (Fig. 5C) . Similar results were obtained with 100-fold-lower (0.01 M) concentrations of peptide (data
FIG. 4. CD8
ϩ Ly49G2 ϩ cells maintain expression of Ly49G2 in culture. Populations of CD8 ϩ Ly49G2 Ϫ and CD8 ϩ Ly49G2 ϩ cells were sorted from the spleens of day 8 LCMV-infected C57BL/6J mice by flow cytometry (final purity ϭ 99 and 84%, respectively) and expanded in culture for 4 days by stimulation against LCMV-infected PECs. Ly49G2 and CD8 expression was reexamined at this time (left-hand panels). Ly49G2-depleted and Ly49G2-enriched CD8 ϩ populations were also investigated for coexpression of the inhibitory Ly49 family members (central panels), Ly49A and Ly49C. The relationship between NK1.1 and Ly49G2 expression by CD8 ϩ cells was also assessed (right-hand panels). The percentage of lymphocytes in each quadrant is indicated.
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on August 28, 2017 by guest http://jvi.asm.org/ not shown). In replicate experiments using 0.01 M GP276-pulsed L5neo3 targets, the average lytic activity mediated by the CD8 ϩ Ly49G2 ϩ subset (110 Ϯ 17) was approximately 26% of that by the CD8 ϩ Ly49G2 Ϫ population (420 Ϯ 95). It is not known whether there is a relationship between this low level of killing by CD8 ϩ Ly49G2 ϩ cells against GP276-pulsed syngeneic targets and that against allogeneic P815 (H2 d ) targets. This could occur if a GP276-induced conformational change in H2 b resembled a ligand for Ly49G2, but that may be unlikely in light of previous studies which found that the nature of the peptide bound to H2D d did not influence recognition by Ly49A expressed on NK cells (3, 16) . Nevertheless, some killer cell immunoglobulin-like receptors (KIR) display a degree of peptide selectivity in their recognition of HLA-B or HLA-C ligands (11, 22) .
Negative signaling in CD8 ؉ cells expressing the Ly49G2 receptor. We questioned whether Ly49G2 could deliver a negative signal to LCMV-specific CTL and whether coexpression of H2D ϩ T cell, where there has been a shift toward the latter as a result of an increased concentration of GP33. In this regard, we might consider the possibility of a role for Ly49 receptors in establishing an appropriate threshold that activating signals delivered via the TCR must cross.
The low level of killing mediated by CD8 ϩ Ly49G2 ϩ cells against GP276-pulsed syngeneic targets might have been due to negative signaling through the Ly49G2 receptor. However, anti-Ly49G2 MAb did not significantly enhance killing against 0.01 M GP276-pulsed L5neo3 (H2D b ) cells (Fig. 6C ). This suggests that the low levels of killing exhibited by CD8 ϩ
Ly49G2
ϩ cells against this peptide are due to a failure to expand CTL clones capable of mediating this effect, rather than inhibition of a preexisting GP276-specific CTL population. Moreover, a 10-fold-higher concentration of GP276 pep- tide did not result in any significant enhancement of killing against syngeneic (H2 b ) L5neo3 targets presenting this peptide, further supporting this hypothesis (Fig. 6D ).
DISCUSSION
We have described a distinct subset of CD8 ϩ cells bearing an activated/memory phenotype, a skewed TCR repertoire, and the inhibitory MHC class I receptor, Ly49G2. Following LCMV infection, these cells display a characteristic pattern of target cell lysis, distinguished by poor killing of allogeneic H2 d targets and of syngeneic targets presenting the GP276 immunodominant peptide. Ly49G2 negatively regulated the killing of H2D d -expressing syngeneic (H2 b ) cells pulsed with GP33 or NP396 peptides, but negative signaling through this receptor could not be shown to account for the absence of allospecific or GP276-specific killing in the CD8 ϩ Ly49G2 ϩ fraction. In support of our observations is a recent report (32) which describes reduced numbers of GP276 peptide-loaded MHC class I tetramer ϩ and GP276-specific gamma interferon-producing CD8 ϩ cells in day 8, LCMV-infected C57BL/6 mice, transgenic for the Ly49A receptor (for which H2 d is also a ligand), relative to nontransgenic controls. Consistent with our Ly49G2 data for normal mice, the numbers of CD8 ϩ cells specific for GP33 and NP396 in Ly49A-transgenic and nontransgenic mice were similar. Here we provide the first report demonstrating negative signaling through an Ly49 receptor on a population of virus-specific T cells from normal, wild-type mice. In humans, members of another family of MHC class I inhibitory receptors, KIR, have been found in a small but significant population of mainly CD8 ϩ T cells, coexpressing surface markers consistent with a memory phenotype (13, 14) . At an effector level, cytotoxicity mediated by superantigen-stimulated human T cells that express the KIR NKB1 was diminished by ligation to its HLA Bw4 ligand (19) . High proportions of KIR ϩ T cells have been detected in human immunodeficiency virus (HIV) patients; these include HIV-specific CTLs, to which MAb against KIR restored cytolytic activity and cytokine production (5, 8) . Collectively, these results indicate that NK cell receptors may regulate virus-induced T-cell responses.
Further studies are required to elucidate the significance of inhibitory MHC class I receptors on the T-cell response to viral infection, and in this regard mice transgenic for Ly49 family members will be beneficial. One appealing possibility is that the presence of Ly49 receptors on the surface of CD8 ϩ T cells, with the ability to interact with antigen-modified self-MHC class I molecules, may modulate the virus-induced TCR repertoire. Here we have provided evidence for the exclusion of elements of the CD8 ϩ T-cell repertoire in a subpopulation coexpressing the negative-signaling NK cell receptor molecule, Ly49G2.
